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Amyotrophic lateral sclerosis (ALS) is a spontaneous, relentlessly progressive motor neuron disease, usually
resulting in death from respiratory failure within 3 years. Variation in the genes SOD1 and TARDBP accounts
for a small percentage of cases, and other genes have shown association in both candidate gene and
genome-wide studies, but the genetic causes remain largely unknown. We have performed two independent
parallel studies, both implicating the RNA polymerase II component, ELP3, in axonal biology and neuronal
degeneration. In the ﬁrst, an association study of 1884 microsatellite markers, allelic variants of ELP3 were
associated with ALS in three human populations comprising 1483 people (P 5 1.96 3 10
29). In the second,
an independent mutagenesis screen in Drosophila for genes important in neuronal communication and sur-
vival identiﬁed two different loss of function mutations, both in ELP3 (R475K and R456K). Furthermore, knock
down of ELP3 protein levels using antisense morpholinos in zebraﬁsh embryos resulted in dose-dependent
motor axonal abnormalities [Pearson correlation: 20.49, P 5 1.83 3 10
212 (start codon morpholino)
and 20.46, P 5 4.05 3 10
29 (splice-site morpholino), and in humans, risk-associated ELP3 genotypes corre-
lated with reduced brain ELP3 expression (P 5 0.01). These ﬁndings add to the growing body of evidence
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Advance Access published on November 7, 2008implicating the RNA processing pathway in neurodegeneration and suggest a critical role for ELP3 in neuron
biology and of ELP3 variants in ALS.
INTRODUCTION
Spontaneous, relentlessly progressive motor neuron degener-
ation occurs in several diseases of humans. The commonest
adult onset human motor neuron disease is amyotrophic
lateral sclerosis (ALS), which usually results in death from
respiratory muscle weakness within 3 years. In 5–10% of
cases there is a family history of ALS and about a quarter of
these are attributable to mutation in the superoxide dismutase
(SOD1)o rTAR-DNA binding protein 43 (TARDBP) genes.
The genetic contribution to sporadic ALS is largely
unknown, but candidate gene association studies have revealed
SOD1 mutations in 1–7% of cases and TARDBP mutations in
0.5–5% (1–3).
Single-nucleotide polymorphism (SNP) based genome-wide
association studies have been inconclusive. One small study
has not shown a signiﬁcant association (4). A larger study
using a DNA pooling approach to prioritize SNPs has identi-
ﬁed ALS-associated variants in an uncharacterized gene,
FLJ10986 (5). By combining with other data sets, a Dutch
study has identiﬁed ALS-associated variants in the genes
ITPR2 and DPP6 (6,7). The combination of some of the
Dutch study samples with further samples from an Irish popu-
lation detected DPP6 as the most strongly associated variant
but this did not reach statistical signiﬁcance (8). Nevertheless,
the appeal of genome-wide association studies is that any
genetic association will provide an insight that would not be
possible with a candidate gene approach. Although SNP-based
studies are simple to perform and have excellent genomic
coverage, microsatellite-based studies provide an alternative
view of the genome and may be more likely to detect rare
variants (9). Similarly, mutagenesis in small organisms fol-
lowed by screening for neurodegeneration phenotypes may
reveal genes critical for motor neuron function that are not
found by other methods. We therefore performed two indepen-
dent studies to identify genes important in neuronal function or
survival: the ﬁrst, a microsatellite-based genetic association
study of ALS in humans and the second, a mutagenesis
screen in Drosophila. In both cases, variants of the same
gene, elongator protein 3 (ELP3) were identiﬁed as critical
for axonal biology, and this was supported by further func-
tional studies.
RESULTS
Human association study
Demographic features of the study populations are shown in
Supplementary Material, Table S1. We used a multistage
design to examine a population from the UK with 1884 micro-
satellite markers, which were then ranked by strength of
association (Supplementary Material, Figs S1–S4) and
followed-up by replication studies in two other populations
from the USA and Belgium and ﬁne mapping using SNPs.
Four markers were followed-up, two on chromosome 3 and
two on chromosome 8, each pair about 1 Mb apart. We used
permutation to correct for the multiple testing inherent in
examination of multiple microsatellite alleles as instituted in
the program CLUMP. Alleles of D8S1820, a 15-allele
marker, were associated with ALS (P ¼ 1.96   10
29) (Sup-
plementary Material, Table S2). At the end of the permutation
procedure, CLUMP had grouped the alleles of D8S1820 into
two groups: alleles 1, 6, 10, 14 and 15 (hereafter called the
protection-associated alleles), and the remaining alleles (here-
after called the risk-associated alleles) (Supplementary
Material, Table S3). To better understand the risk associated
with the two allelic groups, we performed a 2   2 x
2 test for
independence of the allelic groups with ALS. We again con-
ﬁrmed a highly signiﬁcant association in an overall analysis
stratiﬁed for the populations, with an odds ratio of 0.46,
95% CI 0.35–0.60, P ¼ 8.94   10
29 (Table 1). Each study
population also showed the association with a similar odds
ratio (Breslow–Day test for homogeneity P ¼ 0.42). Bioinfor-
matics analysis with the programs ePCR and BLAT conﬁrmed
a unique location of D8S1820 in intron 10 of the ELP3 gene.
The extent of genomic coverage by our microsatellite selec-
tion is difﬁcult to estimate. The markers had a mean spacing of
1.5 Mb and a median spacing of 0.67 Mb covering all auto-
somes and the X chromosome, 46% targeted to candidate
regions and 54% targeted to gene-dense regions, but we
expect that there will be large genomic regions not included
in this analysis.
The relationship of linkage disequilibrium between SNPs
and microsatellite alleles is complex and often weak for
some alleles, but may extend long distances (9). Consequently,
translating a microsatellite allelic association into an SNP or
haplotype association can be difﬁcult. To examine patterns
of linkage disequilibrium in the region as a prelude to ﬁne
mapping, we analyzed D8S1820 alleles in the Utah CEPH
(CEU) HapMap samples (http://www.hapmap.org). As
expected, we observed a complex pattern of linkage disequili-
brium with neighbouring SNPs (data not shown).
To search for a functional variant, we selected 61 tag-SNPs in
a n da r o u n dt h eELP3 gene for ﬁne-mapping studies in the study
populations (Supplementary Material, Table S4). We observed
the same linkage disequilibrium pattern in each population
(Fig. 1, Supplementary Material, Figs S5 and S6). One SNP,
rs13268953, showed weak association with ALS (stratiﬁed
P ¼ 0.029, unstratiﬁed P ¼ 0.030), but this did not survive
Bonferroni correction for multiple testing, nor was it signiﬁ-
cantly associated with ALS in the individual study populations.
No other SNPs showed association.
To search for a haplotypic association, we ﬁrst simpliﬁed
the microsatellite information by examination of the individ-
ual allelic associations. This showed that the signal came
most strongly from allele 6, which was under-represented in
cases compared with controls (case frequency 0.027, controls
0.057). We then sought a two-marker haplotype with allele 6,
testing each SNP in turn using the omnibus haplotype test
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rs12682496 gave an omnibus P-value of 2.31   10
26 (cor-
rected for 61 SNPs, P ¼ 1.41   10
24), with the allele
6-rs12682496 C haplotype being strongly associated with
ALS (P ¼ 1.05   10
26). This haplotype was also associated
with ALS in each of the study populations.
Mutagenesis screen in Drosophila
In parallel, and independently of the genetic association study,
we performed a forward ethyl methanesulphonate (EMS)-
based mutagenesis screen in Drosophila using eyFLP techno-
logy (11) to discover genes involved in synaptic transmission
and neuronal survival or development (12). We retained 138
mutants with defective ‘on’ and ‘off’ transients as candidate
mutants (12). Mutations identiﬁed using this screening strat-
egy usually affect well-characterized processes involved in
presynaptic function, including exocytosis, endocytosis and
neuronal survival (13,14).
One of the complementation groups encompassed two lethal
alleles showing striking electroretinogram (ERG) phenotypes.
The photoreceptor layer depolarized less in response to a one
second light pulse and the on and off transients were also dra-
matically reduced when compared to controls, suggesting
abnormal neuronal communication (Fig. 2A and B).
To analyze the integrity of the homozygous mutant photo-
receptors, we labeled them with anti-chaoptin (mAb 24B10),
an antibody that labels the photoreceptor membrane. In both
mutants the R7 and R8 photoreceptors projected into the
medulla, but the projection pattern was disrupted and the
array of photoreceptor terminals was disordered (Fig. 2C).
These data suggest that the defects in neuronal communication
we identiﬁed might arise, at least in part, from altered axonal
targeting and synaptic development.
We mapped the mutants to cytological interval 24F2 of the
Drosophila genome and found close linkage to P-element
KG05280. We conﬁrmed this with a complementation test
using a cytologically mapped deﬁciency uncovering several
genes in this region (Fig. 2D) (15). Sequencing of 20 kb
genomic DNA surrounding KG05280 (Fig. 2E) revealed
mutations R475K (elp3
1) and R456K (elp3
2)i nDrosophila
ELP3 (Fig. 2F). This gene is highly homologous to human
ELP3, being 82% identical and 91% similar. Both mutated argi-
nines are conserved across species and are part of the signature
sequence of the GCN5-related acetyl transferase (GNAT)
domain of the enzyme (Fig. 2G). In a second complementation
test, P{GawB}-NP0434, a lethal transposon molecularly
mapped to the ELP3 gene, failed to complement elp3
1 and
elp3
2, further conﬁrming that the lethality of the mutants and
the lesions in ELP3 mapped to the same locus. Taken together,
these data independently identify ELP3 as a critical regulator of
axon targeting and synaptic communication, and suggest the
GNAT domain plays a signiﬁcant role in this process. Further-
more, the data suggest that it is a loss of function of ELP3 that
leads to neuronal defects.
ELP3 expression in humans and transgenic mice
All genes so far known to play a causal role in ALS are
expressed in motor neurons (16). To explore the functional
role of ELP3, we examined lumbar spinal cord tissue of
people who died of non-neurological conditions by staining
with rabbit anti-ELP3 antibody. We observed ELP3 protein in
human spinal motor neurons Supplementary Material, Fig. S7).
Since SOD1 mutations remain the most common genetic
cause of ALS, we explored the possible changes in ELP3
Figure 1. A scatterplot of the linkage disequilibrium between common alleles
of microsatellite D8S1820 and neighboring SNPs in controls of the study
population. The position of the ELP3 gene is shown as a red bar below the
X-axis. Marker D8S1820 is marked by the central vertical arrow and
rs12682496 by the right vertical arrow. Because of the multi-allelic nature
of microsatellite markers it is difﬁcult to show patterns of LD using the con-
ventional triangle plots used for SNPs (but see Supplementary Material, Figs
S5 and S6). This graph plots the pairwise LD between each SNP and the
common microsatellite alleles, with the strength of LD represented by the
P-value for a x
2 test of association. As can be seen, the pattern of LD with
neighboring SNPs is complex, the strength of LD varies for different alleles,
and LD may extend long distances.
Table 1. Alleles of marker D8S1820 as grouped by CLUMP, analyzed by x
2 test
Allelic ratios (cases, controls; protection-associated: risk-associated) Odds ratio (95% CI) P-value n (cases, controls)
UK 36:538, 64:516 0.54 (0.35–0.83) 0.004 287, 290
USA 45:563, 60:344 0.46 (0.30–0.69) 1.41   10
24 304, 202
Belgium 12:368, 39:381 0.32 (0.16–0.62) 3.96   10
24 190, 210
Total: stratiﬁed test As for each country 0.46 (0.35–0.60) 8.95   10
29 781, 702
Total: unstratiﬁed test 93:1469, 163:1241 0.48 (0.37–0.63) 4.34   10
28 781, 702
Counts and association results for alleles of marker D8S1820 analyzed as a bi-allelic system of protection-associated alleles against risk-associated
alleles. Alleles were classiﬁed after permutation testing by CLUMP.
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robust expression of ELP3 in the ventral and dorsal part of the
spinal cord both in SOD1
WT and SOD1
G93A transgenic ALS
mice (Supplementary Material, Fig. S8). There was no differ-
ence in expression between the two spinal cord regions, and no
variation of expression in the ventral cord during disease pro-
gression. Immunostaining of the ventral horn showed clear
ELP3 expression in motor neurons (Supplementary Material,
Fig. S9).
To elucidate whether a loss of ELP3 function was indeed the
mechanism in the ALS population, we determined levels of
ELP3 expression in carriers of the ELP3 genetic variants. In
human cerebellar tissue from control individuals, 15% more
ELP3 protein was observed in those carrying protection-
associated alleles than those carrying risk-associated alleles
only (n ¼ 18, t-test P ¼ 0.01, Fig. 3A and B). In motor cortex
from individuals with ALS, 59% more ELP3 protein was
observed in those carrying protection-associated alleles
than those carrying risk-associated alleles only (n ¼ 17, t-test
P ¼ 0.01, Fig. 3C and D).
Knockdown of ELP3 in zebraﬁsh
Based on these ﬁndings, we next investigated the signiﬁcance of
a loss of ELP3 function in a zebraﬁsh model. The protein
sequence of ELP3 is highly conserved in zebraﬁsh, with
91.3% identity and 97.3% similarity to human ELP3. Western
blot analysis of zebraﬁsh embryos 30 h post-fertilization
injected with an ELP3-speciﬁc RNA-blocking ATG morpholino
(ATG-MO), showed a dose-dependent lowering of ELP3
protein levels (Fig. 4A). In line with axonal targeting defects
in ELP3 mutant Drosophila photoreceptors, injection of zebra-
ﬁsh embryos with 6 ng of ATG-MO demonstrated abnormal
branching in motor axons in 67.5% of the cases, compared
with17.8% of embryos injected with6 ng of control morpholino
(Ctr-MO, Fig. 4B and C). Similar ﬁndings were obtained on
injection of 9 ng of an ELP3-speciﬁc splice-site-targeting mor-
pholino (Sp-MO), which also induced dose-dependent abnormal
branching in 63.6% of embryos (Table 2). Moreover, at the
highest dose tested the axonal length of ventral motor neuron
axons was signiﬁcantly decreased by 14.7% (ATG-MO) and
18.7% (Sp-MO) (Fig. 4D). This effect too was dose-dependent
for both morpholinos [Pearson correlation: 20.49, P ¼ 1.83  
10
212 (ATG-MO) and 20.46, P ¼ 4.05   10
29 (Sp-MO)].
Embryos injected with Ctr-MO showed no defects in these par-
ameters compared with buffer-injected embryos.
DISCUSSION
This study provides four lines of evidence implicating the
RNA polymerase II component ELP3 as critically important
to the axonal biology of neurons and supporting the initial
observation of involvement in human motor neuron disease.
First, in an association study of 1483 individuals, ELP3 was
associated with human motor neuron degeneration in the
form of ALS in three different populations. Secondly, an inde-
pendent mutagenesis screen in Drosophila for defects in neur-
onal communication and survival identiﬁed two different loss
of function ELP3 mutations that each conferred abnormal
photoreceptor axonal targeting and synaptic development,
possibly signifying neurodegeneration. Thirdly, knockdown
of ELP3 in zebraﬁsh using antisense morpholino technology
resulted in a dose-dependent shortening and abnormal branch-
ing of motor neurons with no concomitant morphological
abnormality. Finally, risk-associated ELP3 alleles were associ-
ated with lower brain ELP3 expression in humans. These ﬁnd-
ings strongly implicate ELP3 in axonal biology and as a gene
conferring risk of neuronal degeneration.
The published SNP-based genome-wide association studies
in ALS have not detected associated ELP3 variants (4–6), but
the protection-associated ELP3 microsatellite variants have a
total frequency of 11%, so approaches using tag-SNPs
might not detect them. Although we too did not see any
single SNP associations using a dense set of SNPs in and
around ELP3, we did identify a haplotype between microsatel-
lite allele 6 and the C allele of rs12682496, suggesting either
that an untyped causal variant lies on this haplotype or the
haplotype itself is functional. Although in general microsatel-
lites are not thought to be functional, differences in gene
expression may be conferred by polymorphic microsatellites
in regulatory regions (17–19) or in coding sequences (20).
Consistent with an important genomic function, the
D8S1820 microsatellite repeat is conserved within ELP3 in
chimpanzees and rhesus monkeys, which suggests that it pre-
dates the common ancestor of apes and rhesus monkeys and is
therefore at least 25 million years old.
The ELP3 protein is part of the RNA polymerase II complex
and is involved in RNA processing (Supplementary Material,
Table S5) (21). It contains an Fe4S4 cluster and is involved in
histone acetylation (22), RNA elongation (21), modiﬁcation of
tRNA wobble nucleosides (23) and an unknown catalytic
function related to free radical reactions. Alteration in RNA
processing is an element in the pathophysiology of several
motor neuron disorders and neurodegenerative diseases,
including ALS (2,24,25), hereditary motor neuronopathies 5
[MIM600794] and 6 [MIM604320], Charcot–Marie–Tooth
disease type 2D [MIM601472], spinal muscular atrophy
[MIM253300], familial dysautonomia [MIM223900] (26) and
spinocerebellar ataxia 7 [MIM164500] (27) (Supplementary
Material,TableS5).Inaddition,trinucleotiderepeatneurodegen-
erativediseaseshavebeenproposedtobetheresultofadisruption
of nuclear organization that prevents proper RNA processing.
Figure 2. Drosophila ELP3 mutants identiﬁed in a screen for defects in neuronal communication. (A and B) ERG recordings and quantiﬁcation of ‘on’ and ‘off’
(arrowheads in A) amplitudes of control and ELP3 mutant eyes. Black: on- and grey off-transients. Controls n ¼ 48, elp3
1 n ¼ 59, elp3
2 n ¼ 57. Error bars
indicate standard error of the mean. t-test: Control-elp3
1, on: P ¼ 1.86   10
216, off: P ¼ 1.78   10
214; control-elp3
2, on: P ¼ 1.58   10
219, off: P ¼
7.90   10
210.( C) Confocal microscopy showing the photoreceptor axon projections in the medulla labeled with anti-chaoptin. In the mutants photoreceptors
arrive and synapse in the medulla, but the synapses are not properly organized in rows. Scale bars 20 mm. (D) Mapping of ELP3 mutations. KG P-elements
used for ﬁne-mapping located in the 24C5-8 cytological region. Numbers under markers are tested/recombinant ﬂies. (E) Recombination distances (cM) for
the three P-elements closest to the mutant phenotype (lethality). The position of ELP3 in relation to KG05280 is indicated with a red asterisk and the 20 kb
sequenced region as a grey bar. (F) ELP3 mutations (arrows). No mutations were found in surrounding genes. (G) Schematic representation of ﬂy ELP3
(552aa) and mutations elp3
1 and elp3
2.
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neuron degeneration comes from its effect on transcription
through histone acetylation. Heat shock proteins (HSPs) are
molecularchaperoneswhoseexpressionisincreasedinresponse
to cellular stress. Motor neurons have a high threshold for acti-
vating HSPs, making them particularly vulnerable to stressors,
including mutant SOD1 (28). ELP3 directly regulates HSP70
expressionbyacetylationofhistonesH3andH4(29),andthere-
fore one possible explanation for the association of high-
expressing ELP3 alleles with protection from motor neuron
degeneration in humans is the ability to increase the transcrip-
tion of HSP70. Indeed, intraperitoneal injection of HSP70 pro-
longed the lifespan of G93A SOD1 transgenic mice (30).
The association of ELP3 variants with motor neuron
degeneration and axonal biology in general increases the evi-
dence that the RNA processing pathway is of particular
importance to neurons, and provides a potential therapeutic
target for treatment of ALS.
MATERIALS AND METHODS
Study patients
Three geographically distinct populations were studied, from
the UK, Belgium and the US (Supplementary Material,
Table S1). All individuals were of European ancestry. Individ-
uals attending specialist ALS clinics in each participating
center were invited to participate. The diagnosis of ALS was
made according to the El Escorial criteria after full investi-
gation to exclude other causes. Patients with familial ALS
were excluded but samples were not routinely screened
for SOD1 mutations. Controls were unrelated individuals
travelling with the patient. In the UK samples, 31% were
blood donors from the same geographical region. The study
was ethically approved by the institutional review board of
each participating institution.
Genetic association methods
We used a dual strategy to select microsatellite markers. Using
the program MaGIC (31) we generated one set of markers to
target genes and regions from candidate pathways based on
existing hypotheses of ALS causation and a second set to
target gene-dense regions throughout the genome. We used an
initial DNA pooling strategy in the UK samples to prioritize
the microsatellite markers for further study by conventional gen-
otyping of individual DNA samples. DNA pools were made by
standard methods (32), with each pool comprising non-
overlapping samples grouped by phenotype. The smallest pool
comprised57individualsandthelargest123.Microsatellitegen-
otypes were analyzed by electrophoresis of ﬂuorescently labeled
PCR products using an Applied Biosystems ABI 3100 or
3130XL Genetic Analyzer (UK, Belgium) or LiCor Genotyping
System (USA). Pool quality was validated by allele frequency
estimation of microsatellite alleles and SNPs (33). The results
Figure 3. Western blot analysis of ELP3 protein expression in human control
cerebellar tissue and ALS motor cortex. (A) Western blot analysis of cerebel-
lar tissue samples from controls carrying risk-associated alleles (Risk) or at
least one protection-associated allele (Protection). (B) Expression of ELP3
protein as a ratio to b-actin in cerebellar tissue from controls carrying
risk-associated alleles (triangles, n ¼ 13) or at least one protection-associated
allele (diamonds, n ¼ 5). (C) Western blot analysis of ALS motor cortex tissue
samples carrying risk-associated alleles (Risk) or at least one protection-
associated allele (Protection). (D) Expression of ELP3 protein as a ratio to
b-actin in ALS motor cortex samples carrying risk-associated alleles (tri-
angles, n ¼ 9) or at least one protection-associated allele (diamonds, n ¼ 8). Figure 4. Morpholino-induced knockdown of ELP3 affects motor neuron
axonal branching and length. (A) Western blot of ELP3 following treatment
with Ctr-MO and ATG-MO. Maximal ELP3 knockdown was 44%. (B)
ELP3 knockdown by Sp-MO and ATG-MO resulted in increased branching
of motor axons (right) compared with control (left). (C) There was a dose-
dependent decrease in axonal length of motor neurons for both Sp-MO and
ATG-MO. Results show SEM ( P , 0.01;   P , 1.0   10
27). P-values at
each dose of ATG-MO compared with 6.0 ng Ctr-MO were 3.0 ng: P ¼
0.0024; 4.5 ng: P ¼ 1.19   10
28; 6.0 ng: P ¼ 7.68   10
211. P-values at
each dose of Sp-MO compared with 6.0 ng Ctr-MO were 6.0 ng: P ¼
0.0084; 7.5 ng: P ¼ 0.0039; 9.0 ng, P ¼ 6.94   10
29. Scale bar 50 mm.
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that included factors for pooling and genotyping artifacts. We
gave highest priority for follow-up to adjacent markers in the
top 1% of results. Prioritized markers were genotyped in the
individual UKsamples for conﬁrmation. Conﬁrmed associations
were then genotyped in the individual Belgian samples, and
replicated results further validated in the US samples, also by
typing each DNA individually. Replicated associations were
then analyzed further in the study populations by ﬁne-mapping
of relevant loci with SNPs.
The D8S1820 dinucleotide repeat alleles were numbered
sequentially from the smallest (90 bp¼allele 1) to the largest
(118 bp¼allele 15) for PCR products ampliﬁed using the
amplimers at http://www.gdb.org. SNPs were analyzed by ﬂu-
orescent end-point PCR using a TaqMan assay or the Illumina
317K Human Inﬁnium array.
Protein studies of human tissue
Brain samples. Cerebellar tissue samples were obtained from
non-Alzheimer disease control brains from the Alzheimer’s
Disease Research Center at Massachusetts General Hospital.
ALS tissue samples were obtained from the Medical Research
Council Brain Bank at the MRC Centre for Neurodegeneration
Research, King’s College London. Brain tissue homogenates
were prepared using a hand-held homogenizer in RIPA
buffer [50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1%
NP-40, 12 mM deoxycolic acid] containing protease inhibitors
(Roche Applied Science, Wellesley, MA). Bradford protein
concentration assays were carried out using standard proto-
cols. Rabbit anti-b-actin was obtained from Sigma, St Louis,
MO. Blots were incubated with horse-radish peroxidase-
coupled secondary anti-rabbit antibody (Jackson ImmunoRe-
search, West Grove, PA) or secondary anti-rabbit alkaline
phosphatase-coupled antibody (Sigma). Semi-quantitative
analysis of ELP3 and b-actin protein levels was carried out
by scanning of western blots and densitometry analysis
using Scion Image or ImageQuant software. Each sample
was tested between two and eight times.
Spinal cord samples. Parafﬁn-embedded spinal cord tissue
ofcontrolswerestainedwithrabbitanti-ELP3antibodyandvisu-
alized using 3,30-diaminobenzidine tetrahydrochloride (Sigma).
Western blotting. Western blotting was performed using
primary rabbit polyclonal anti-ELP3 antibody raised against
gel-puriﬁed GST-(yeast) ELP3, rabbit polyclonal anti-ELP3
antibody raised against speciﬁc peptide sequences of human
ELP3 (CPGGPDSDFEYSTQSY and HKVRPYQVELVRR-
DYV) and rabbit anti-b-actin.
Transgenic mice
B6SJLTgN (SOD1
WT) and B6SJLTgN (SOD1
G93A)1Gur
transgenic mice were purchased from the Jackson Laboratory
(Bar Harbor, ME). Spinal cord was dissected and homogen-
ized in RIPA buffer. Western blotting was performed using
primary antibodies of rabbit polyclonal anti-ELP3 antibody
raised against gel-puriﬁed GST-ELP3 and mouse monoclonal
anti-b-actin antibody (Sigma). Blots were incubated with
either secondary anti-rabbit or anti-mouse alkaline
phosphatase-coupled antibody (Sigma). Immunohistochemical
studies of spinal cord were performed on transgenic
SOD1
G93A and age-matched transgenic SOD1
WT mice. Fresh
frozen sections were co-stained with mouse anti-SMI32
(Sternberger Monoclonals) and rabbit anti-ELP3 antibody.
The sections were incubated with either Alexa Fluor 488 anti-
mouse or AlexaFluor 555 anti-rabbit secondary antibody
(Molecular Probes).
Drosophila methods
Mutagenesis and phenotyping. Flies were grown on standard
molasses medium. We performed a forward EMS-based muta-
genesis screen using the eyFLP technology (11) to discover
genes involved in synaptic transmission and neuronal survival
or development (12). Mutant ﬂies were tested using a counter-
current phototaxis assay to retain blind ﬂies, and using ERG
ﬁeld potential recordings of the eye during a light ﬂash, to deter-
mine synaptic transmission efﬁciency (12). In a normal ﬂy eye,
six of the eight photoreceptors of each ommatidium (R1–R6)
project into the ﬁrst optic ganglion, the lamina, while the other
two (R7 and R8) project deeper into the second optic ganglion,
the medulla, in a stereotyped manner. Examination of this
projection pattern allows the quick assessment of changes in
neuronal targeting or gross synaptic structure (34). KG
P-elements for mapping were obtained from the Bloomington
Table 2. Knockdown of ELP3 in Zebraﬁsh
Embryos showing .2/20
branching axons (%)
a
Odds ratio (CI) compared
with Ctr-MO
x
2 P-value Branching axons per
embryo (%)
b
Ctr-MO (6.0 ng), n ¼ 45 17.8 4.1
ATG-MO (3.0 ng), n ¼ 35 48.6 4.4 (1.6–12.0) 0.003 8.7
ATG-MO (4.5 ng), n ¼ 61 50.8 4.8 (1.9–11.9) 4.89   10
24 9.4
ATG-MO (6.0 ng), n ¼ 40 67.5 9.6 (3.5–26.4) 3.34   10
26 10.1
Sp-MO (6.0 ng), n ¼ 38 28.9 1.9 (0.7–5.3) 0.23 5.4
Sp-MO (7.5 ng), n ¼ 37 37.8 2.8 (1.0–7.8) 0.04 7.3
Sp-MO (9.0 ng), n ¼ 33 63.6 8.1 (2.9–23.0) 3.47   10
25 12.0
Table showing knockdown of ELP3 using two different antisense morpholinos results in dose-dependent abnormal branching of primary motor neurons.
aFor ATG-MO, Spearman correlation: 0.33 (P ¼ 5.28   10
26), Kruskal–Wallis test P ¼ 5.33   10
25; for Sp-MO, Spearman correlation: 0.33 (P ¼ 2.57  
10
25), Kruskal–Wallis test P ¼ 3.80   10
24.
bFor ATG-MO, Spearman correlation: 0.30 (P ¼ 3.21   10
25), Kruskal–Wallis test P ¼ 1.35   10
24; for Sp-MO Spearman correlation: 0.38(P ¼ 1.36   10
26),
Kruskal–Wallis test P ¼ 3.91   10
25.
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þ} to
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1 or 2
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þ}FRT40A
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immunohistochemistry on adult brains were performed as
described (14,20). The lethal insertion P{GawB}NP0434 that
fails to complement mutant ELP3 alleles was obtained from
the Kyoto Drosophila Genetic Resource Center, Japan. For
sequencing, yw eyFLP GMRLacZ; elp3
1o r2P{y
þ}F R T 4 0 A
iso/
CyO, Kr::Gal4 UAS::GFP animals were crossed to yw eyFLP
GMRLacZ; P{y
þ}F R T 4 0 A
iso and heterozygous DNA was
ampliﬁed using PCR, sequenced and analysed with Seqman
(DNAStar). To identify the gene mutated, we determined the
recombination distance between the lethal lesions and molecu-
larly mapped markers on the chromosome (P-elements).
Immunohistochemistry. Anti-chaoptin serum (mAb 24B10)
was obtained from the Developmental Studies Hybridoma
Bank and used at a concentration of 1:200; secondary Alexa
555 conjugated antibodies were used at a concentration of
1:200 (Invitrogen). Images were captured using a Radiance
BioRad confocal microscope and processed with ImageJ and
Photoshop 7.0.
Zebraﬁsh methods
Adult zebraﬁsh and embryos were maintained and staged as
described (35). The following morpholinos to knock down
the expression of zebraﬁsh ELP3 were obtained from Gene
Tools (LLC, Corvallis): An ATG-morpholino targeting the
ATG start codon: 50-TGGCTTTCCCATCTTAGACACAAT
C-30 (ATG-MO), a splice morpholino targeting a splice site:
50-CTCAAGTCACCTGACGTATAAAACA-30 (Sp-MO). A
reversed ATG sequence 50-CTAACACAGATTCTACCCTTT
CGGT-30 (Ctr-MO) was a control. Morpholinos were injected
using a FemtoJet
w (Eppendorf). The data shown in this manu-
script were obtained by injecting, at the highest doses used, a
total of 6, 6 and 9 ng for ATG-MO, Ctr-MO and Sp-MO,
respectively. Primary antibodies for western blot analyses of
whole embryos 30 h post-fertilization were rabbit anti-Elp3
and anti-a-tubulin (Sigma). The blots were incubated with
either secondary anti-rabbit or anti-mouse alkaline
phosphatase-coupled antibody (Sigma). Axonal defects were
evaluated as described (36). Embryos were scored as affected
when two or more axons of the 20 analyzed per embryo (ten
rostral, ventral motor nerves per hemisegment along the yolk
sac extension) showed branching.
All animal studies were approved by the institutions in
which they took place.
Statistical methods
Ranking of microsatellite associations for individual genotyp-
ing. DNA pool genotypes were analyzed by a modiﬁcation of
the meta-regression procedure in STATA 8.0 (Stata Inc.) (37).
The pool estimate of frequency was analyzed for each allele
and the best P-value per marker used to rank the results.
The regression equation was F ¼ bcC þ ba A þ bsS þ K,
where F was the pool allele frequency, C was 1 for case, 0
for control, A was pool mean age of onset or sample acqui-
sition for a control and S was the proportion of males. A
test of the hypothesis that bc ¼ 0 yielded the test statistic.
Results were ranked by the size of the statistic. The sampling
variance was pq/2N. The main source of error in pooled
analysis of microsatellite genotypes is the degree of stutter
(false bands of lower intensity representing PCR products in
which one or more repeats has been lost) and differential
ampliﬁcation (the degree to which smaller alleles are ampli-
ﬁed preferentially to larger alleles in PCR reactions). These
errors were estimated from data for 400 microsatellite
markers typed in 16 individuals, and the expected resulting
error for the pooled genotypes was modeled in Mx (38).
This was s
2 ¼ 0.215
2 p(12p)
1.476 for trinucleotide and
tetranucleotide repeats, and s
2 ¼ 0.171
2 p(12p)
1.379 for
dinucleotide repeats.
Individual genotyping. Microsatellites are multi-allelic.
Because the multiple ways different alleles can be combined
increases the chances of ﬁnding an association, an unbiased
approach is required that accounts for the inherent multiple
testing. We therefore used the permutation-based x
2 test
implemented in the program CLUMP, which was written
speciﬁcally for the association analysis of multi-allelic markers
(39). Stratiﬁed analyses of all populations were performed by
Fisher’s method for combining kP -values, x2
2k ¼  2
Pk
1 lnðPÞ
for CLUMP-derived P-values and the Mantel–Haenzsel x
2
test for all other tests. Unstratiﬁed analyses were performed by
treating the three populations as one. Single SNP and haplotypic
association analyses were carried out using PLINK (10) and
visualized in Haploview (40). Population structure was analyzed
using a x
2 sum statistic for 99 unlinked markers, estimation of
Wright’s coefﬁcient FST assuming a single population, and
using the program Structure (41).
Protein expression. Semi-quantitative western blot data were
log-transformed to normal. Normality was tested by inspection
of standardized residual plots, histograms and the Kolmo-
gorov–Smirnov test (P ¼ 0.15). Equal variances were tested
by Levene’s test for homogeneity of variances (P ¼ 0.13).
Analysis was by homoscedastic t-test. Two-tailed P-values
were reported.
Zebraﬁsh. Zebraﬁsh morpholino experiments were analyzed
by x
2 test, Pearson or Spearman correlation and Kruskal–
Wallis tests in the program SPSS 13.0 (SPSS Inc., IL, USA).
ACKNOWLEDGEMENTS
We are indebted to H.J. Bellen, P. Tilkin, RN and A. D’Hondt,
RN. We thank Jesper Q. Svejstrup for donation of anti-ELP3
antibody, the Developmental Studies Hybridoma Bank, Iowa
for antibodies, the Bloomington Stock Center and Kyoto
Genetics Resource Center for ﬂies and Cathryn Lewis and
Jean-Marc Gallo for comments.
Human Molecular Genetics, 2009, Vol. 18, No. 3 479Conﬂict of Interest statement. None declared.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG Online.
FUNDING
This work was supported by the Medical Research Council
(UK) to A.A.-C.; ALS Association to A.A.-C. and R.H.B.;
Motor Neurone Disease Association to A.A.-C.; University
of Leuven to W.R.; the Belgian government (Interuniversity
Attraction Poles Programme 6/43—Belgian State—Belgian
Science Policy) to W.R.; VIB to W.R. and P.V.; the Robert
Packard Center for ALS Research to W.R.; the Howard
Hughes Medical Institute to H.R.H.; The National Institutes
of Neurological Disease and Stroke to R.H.B.; the National
Institute on Aging to R.H.B.; the Al-Athel ALS Research
Foundation to R.H.B.; the ALS Therapy Alliance to R.H.B.,
the Angel Fund to R.H.B.; Project ALS to R.H.B.; and the
Pierre L. de Bourgknecht ALS Research Foundation to
R.H.B. For much of this work, A.A.-C. was a Medical
Research Council (MRC) Clinician Scientist Fellow and
C.L.S. was funded by GKT PhD Studentship. P.S. and
H.R.H. were supported by the Howard Hughes Medical Insti-
tute. W.R. was supported through the E von Behring Chair
for Neuromuscular and Neurodegenerative Disorders. P.V.
was supported through a Marie Curie Excellence Grant.
Funding to pay the Open Access Charge was provided by
the Medical Research Council.
REFERENCES
1. Simpson, C.L. and Al-Chalabi, A. (2006) Amyotrophic lateral sclerosis as
a complex genetic disease. Biochim. Biophys. Acta, 1762, 973–985.
2. Sreedharan, J., Blair, I.P., Tripathi, V.B., Hu, X., Vance, C., Rogelj, B.,
Ackerley, S., Durnall, J.C., Williams, K.L., Buratti, E. et al. (2008)
TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis.
Science, 319, 1668–1672.
3. Kabashi, E., Valdmanis, P.N., Dion, P., Spiegelman, D., McConkey, B.J.,
Velde, C.V., Bouchard, J.P., Lacomblez, L., Pochigaeva, K., Salachas, F.
et al. (2008) TARDBP mutations in individuals with sporadic and familial
amyotrophic lateral sclerosis. Nat. Genet., 40, 572–574.
4. Schymick, J.C., Scholz, S.W., Fung, H.C., Britton, A., Arepalli, S., Gibbs,
J.R., Lombardo, F., Matarin, M., Kasperaviciute, D., Hernandez, D.G. et
al. (2007) Genome-wide genotyping in amyotrophic lateral sclerosis and
neurologically normal controls: ﬁrst stage analysis and public release of
data. Lancet Neurol., 6, 322–328.
5. Dunckley, T., Huentelman, M.J., Craig, D.W., Pearson, J.V., Szelinger, S.,
Joshipura, K., Halperin, R.F., Stamper, C., Jensen, K.R., Letizia, D. et al.
(2007) Whole-genome analysis of sporadic amyotrophic lateral sclerosis.
N. Engl. J. Med., 357, 775–788.
6. van Es, M.A., Van Vught, P.W., Blauw, H.M., Franke, L., Saris, C.G.,
Andersen, P.M., Van Den Bosch, L., de Jong, S.W., van ‘t Slot, R., Birve,
A. et al. (2007) ITPR2 as a susceptibility gene in sporadic amyotrophic
lateral sclerosis: a genome-wide association study. Lancet Neurol., 6,
869–877.
7. van Es, M.A., van Vught, P.W., Blauw, H.M., Franke, L., Saris, C.G., Van
den Bosch, L., de Jong, S.W., de Jong, V., Baas, F., van’t Slot, R. et al.
(2008) Genetic variation in DPP6 is associated with susceptibility to
amyotrophic lateral sclerosis. Nat. Genet., 40, 29–31.
8. Cronin, S., Berger, S., Ding, J., Schymick, J.C., Washecka, N., Hernandez,
D.G., Greenway, M.J., Bradley, D.G., Traynor, B.J. and Hardiman, O.
(2007) A genome-wide association study of sporadic ALS in a
homogenous Irish population. Hum. Mol. Genet., 17, 768–774.
9. Payseur, B.A., Place, M. and Weber, J.L. (2008) Linkage disequilibrium
between STRPs and SNPs across the human genome. Am. J. Hum. Genet.,
82, 1039–1050.
10. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A.R.,
Bender, D., Maller, J., Sklar, P., de Bakker, P.I.W., Daly, M.J. et al.
(2007) PLINK: a tool set for whole-genome association and
population-based linkage analyses. Am. J. Hum. Genet., 81, 559–575.
11. Newsome, T.P., Asling, B. and Dickson, B.J. (2000) Analysis of
Drosophila photoreceptor axon guidance in eye-speciﬁc mosaics.
Development, 127, 851–860.
12. Koh, T.W., Verstreken, P. and Bellen, H.J. (2004) Dap160/intersectin acts
as a stabilizing scaffold required for synaptic development and vesicle
endocytosis. Neuron, 43, 193–205.
13. Guo, X., Macleod, G.T., Wellington, A., Hu, F., Panchumarthi, S.,
Schoenﬁeld, M., Marin, L., Charlton, M.P., Atwood, H.L. and Zinsmaier,
K.E. (2005) The GTPase dMiro is required for axonal transport of
mitochondria to Drosophila synapses. Neuron, 47, 379–393.
14. Verstreken,P., Ly,C.V., Venken, K.J.,Koh,T.W., Zhou,Y.and Bellen,H.J.
(2005) Synaptic mitochondria are critical for mobilization of reserve pool
vesicles at Drosophila neuromuscular junctions. Neuron, 47,365–378.
15. Zhai, R.G., Hiesinger, P.R., Koh, T.W., Verstreken, P., Schulze, K.L.,
Cao, Y., Jafar-Nejad, H., Norga, K.K., Pan, H., Bayat, V. et al. (2003)
Mapping Drosophila mutations with molecularly deﬁned P element
insertions. Proc. Natl Acad. Sci. USA, 100, 10860–10865.
16. Pasinelli, P. and Brown, R.H. (2006) Molecular biology of amyotrophic
lateral sclerosis: insights from genetics. Nat. Rev. Neurosci., 7, 710–723.
17. Fuchs, J., Tichopad, A., Golub, Y., Munz, M., Schweitzer, K.J., Wolf, B.,
Berg, D., Mueller, J.C. and Gasser, T. (2007) Genetic variability in the
SNCA gene inﬂuences{alpha}-synuclein levels in the blood and brain.
FASEB J., 22, 1327–1334.
18. Hammock, E.A. and Young, L.J. (2005) Microsatellite instability
generates diversity in brain and sociobehavioral traits. Science, 308,
1630–1634.
19. Yim, J.J., Ding, L., Schaffer, A.A., Park, G.Y., Shim, Y.S. and Holland,
S.M. (2004) A microsatellite polymorphism in intron 2 of human Toll-like
receptor 2 gene: functional implications and racial differences. FEMS
Immunol. Med. Microbiol., 40, 163–169.
20. Kizawa, H., Kou, I., Iida, A., Sudo, A., Miyamoto, Y., Fukuda, A.,
Mabuchi, A., Kotani, A., Kawakami, A., Yamamoto, S. et al. (2005) An
aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and
increases susceptibility to osteoarthritis. Nat. Genet., 37, 138–144.
21. Winkler, G.S., Petrakis, T.G., Ethelberg, S., Tokunaga, M.,
Erdjument-Bromage, H., Tempst, P. and Svejstrup, J.Q. (2001) RNA
polymerase II elongator holoenzyme is composed of two discrete
subcomplexes. J. Biol. Chem., 276, 32743–32749.
22. Winkler, G.S., Kristjuhan, A., Erdjument-Bromage, H., Tempst, P. and
Svejstrup, J.Q. (2002) Elongator is a histone H3 and H4 acetyltransferase
important for normal histone acetylation levels in vivo. Proc. Natl Acad.
Sci. USA, 99, 3517–3522.
23. Huang, B., Johansson, M.J. and Bystrom, A.S. (2005) An early step in
wobble uridine tRNA modiﬁcation requires the Elongator complex. RNA,
11, 424–436.
24. Chen, Y.Z., Bennett, C.L., Huynh, H.M., Blair, I.P., Puls, I., Irobi, J.,
Dierick, I., Abel, A., Kennerson, M.L., Rabin, B.A. et al. (2004) DNA/
RNA helicase gene mutations in a form of juvenile amyotrophic lateral
sclerosis (ALS4). Am. J. Hum. Genet., 74, 1128–1135.
25. Greenway, M.J., Andersen, P.M., Russ, C., Ennis, S., Cashman, S.,
Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J. et al.
(2006) ANG mutations segregate with familial and ‘sporadic’
amyotrophic lateral sclerosis. Nat. Genet., 38, 411–413.
26. Anderson, S.L., Coli, R., Daly, I.W., Kichula, E.A., Rork, M.J., Volpi,
S.A., Ekstein, J. and Rubin, B.Y. (2001) Familial dysautonomia is caused
by mutations of the IKAP gene. Am. J. Hum. Genet., 68, 753–758.
27. Helmlinger, D., Hardy, S., Sasorith, S., Klein, F., Robert, F., Weber, C.,
Miguet, L., Potier, N., Van-Dorsselaer, A., Wurtz, J.M. et al. (2004)
Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing
complexes. Hum. Mol. Genet., 13, 1257–1265.
28. Batulan, Z., Shinder, G.A., Minotti, S., He, B.P., Doroudchi, M.M.,
Nalbantoglu, J., Strong, M.J. and Durham, H.D. (2003) High threshold for
induction of the stress response in motor neurons is associated with failure
to activate HSF1. J. Neurosci., 23, 5789–5798.
480 Human Molecular Genetics, 2009, Vol. 18, No. 329. Han, Q., Lu, J., Duan, J., Su, D., Hou, X., Li, F., Wang, X. and Huang, B.
(2008) Gcn5- and Elp3-induced histone H3 acetylation regulates hsp70
gene transcription in yeast. Biochem. J., 409, 779–788.
30. Gifondorwa, D.J., Robinson, M.B., Hayes, C.D., Taylor, A.R., Prevette,
D.M., Oppenheim, R.W., Caress, J. and Milligan, C.E. (2007) Exogenous
delivery of heat shock protein 70 increases lifespan in a mouse model of
amyotrophic lateral sclerosis. J. Neurosci., 27, 13173–13180.
31. Simpson, C.L., Hansen, V.K., Sham, P.C., Collins, A., Powell, J.F. and
Al-Chalabi, A. (2004) MaGIC: a program to generate targeted marker sets
for genome-wide association studies. Biotechniques, 37, 996–999.
32. Sham, P., Bader, J.S., Craig, I., O’Donovan, M. and Owen, M. (2002)
DNA Pooling: a tool for large-scale association studies. Nat. Rev. Genet.,
3, 862–871.
33. Simpson, C.L., Knight, J., Butcher, L.M., Hansen, V.K., Meaburn, E.,
Schalkwyk, L.C., Craig, I.W., Powell, J.F., Sham, P.C. and Al-Chalabi,
A. (2005) A central resource for accurate allele frequency estimation
from pooled DNA genotyped on DNA microarrays. Nucleic Acids Res.,
33, e25.
34. Clandinin, T.R. and Zipursky, S.L. (2002) Making connections in the ﬂy
visual system. Neuron, 35, 827–841.
35. Westerﬁeld, M. (2003) The Zebraﬁsh Book. The University of Oregon
Press, Eugene, Oregon.
36. Lemmens, R., Van Hoecke, A., Hersmus, N., Geelen, V., D’Hollander, I.,
Thijs, V., Van Den Bosch, L., Carmeliet, P. and Robberecht, W. (2007)
Overexpression of mutant superoxide dismutase 1 causes a motor
axonopathy in the zebraﬁsh. Hum. Mol. Genet., 16, 2359–2365.
37. Knight, J. and Sham, P. (2006) Design and analysis of association
studies using pooled DNA from large twin samples. Behav. Genet., 36,
665–677.
38. Neale, M.C., Boker, S.M., Xie, G. and Maes, H.H. (2003) Mx:. Statistical
Modeling, Box 980126 MCV. Richmond, VA, 23298.
39. Sham, P.C. and Curtis, D. (1995) Monte Carlo tests for associations
between disease and alleles at highly polymorphic loci. Ann. Hum. Genet.,
59, 97–105.
40. Barrett, J.C., Fry, B., Maller, J. and Daly, M.J. (2005) Haploview: analysis
and visualization of LD and haplotype maps. Bioinformatics, 21,
263–265.
41. Pritchard, J.K., Stephens, M. and Donnelly, P. (2000) Inference of
population structure using multilocus genotype data. Genetics, 155,
945–959.
Human Molecular Genetics, 2009, Vol. 18, No. 3 481